当前位置:首页 - 行情中心 - 瑞普生物(300119) - 财务分析

瑞普生物

(300119)

  

流通市值:51.84亿  总市值:72.32亿
流通股本:3.34亿   总股本:4.66亿

瑞普生物(300119)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.94亿元,每股收益0.19元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益488494.64万元,未分配利润176072.26万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产666448.02万元,负债177953.38万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入533,199,134.682,248,962,053.981,587,164,776.49994,096,256.27
营业总成本435,867,665.21,874,332,565.391,314,397,482.78823,889,058.32
营业利润105,375,441.99565,230,235.97326,718,407.91215,890,268.29
利润总额105,078,491.84566,680,053.37326,085,531.64215,106,348.68
净利润93,504,682.67511,016,725.18294,900,963.96193,473,913
其他综合收益----
综合收益总额93,504,682.67511,016,725.18294,900,963.96193,473,913
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计3,378,521,402.173,263,327,707.083,038,546,011.312,926,085,762.65
非流动资产合计3,285,958,772.623,332,613,7943,179,957,029.923,186,502,072.13
资产总计6,664,480,174.796,595,941,501.086,218,503,041.236,112,587,834.78
流动负债合计1,230,804,815.21,344,905,393.371,140,384,582.851,101,472,258.44
非流动负债合计548,728,975.84446,150,180.04432,322,637.83468,485,855.93
负债合计1,779,533,791.041,791,055,573.411,572,707,220.681,569,958,114.37
归属于母公司股东权益合计4,570,430,994.594,496,304,113.264,360,872,233.934,263,706,325.37
股东权益合计4,884,946,383.754,804,885,927.674,645,795,820.554,542,629,720.41
负债和股东权益合计6,664,480,174.796,595,941,501.086,218,503,041.236,112,587,834.78
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计547,363,142.822,138,323,520.771,539,169,685.281,028,613,795.37
经营活动现金流出小计458,227,213.591,760,127,192.171,342,202,344891,854,515.62
经营活动产生的现金流量净额89,135,929.23378,196,328.6196,967,341.28136,759,279.75
投资活动现金流入小计1,008,289,220.33,817,291,917.932,756,212,231.591,943,937,110.36
投资活动现金流出小计833,554,625.023,978,266,527.072,596,845,145.091,940,163,160.38
投资活动产生的现金流量净额174,734,595.28-160,974,609.14159,367,086.53,773,949.98
筹资活动现金流入小计204,000,000725,107,254.95500,386,754.95480,600,254.95
筹资活动现金流出小计188,013,503.58997,568,243.13851,081,798.01715,782,574.22
筹资活动产生的现金流量净额15,986,496.42-272,460,988.18-350,695,043.06-235,182,319.27
汇率变动对现金及现金等价物的影响59,671.0364,250.4854,806.2942,838.52
现金及现金等价物净增加额279,916,691.96-55,175,018.245,694,191.01-94,606,251.02
期末现金及现金等价物余额601,446,606.66321,529,914.7382,399,123.95282,098,681.92
最新报告期:2024-04-08
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
光大证券李晓渊1.181.451.752024-04-08
华创证券陈鹏,雷轶1.131.341.492024-04-06
华安证券王莺,万定宇1.081.421.832024-04-01
兴业证券纪宇泽1.111.271.482024-04-01
西南证券徐卿1.101.351.612024-04-01
TOP↑